Krankheitsängste und Hypochondrische Störung

Krankheitsängste sind weit verbreitet und in ihrer pathologischen Ausprägung in Form der Hypochondrischen Störung (ICD-10) kostenintensiv für das Gesundheitssystem. In den letzten Jahren gab es Fortschritte bei der Erforschung und Entwicklung effektiver psychotherapeutischer Behandlungen. Kognitiv-verhaltenstherapeutische Therapiekonzepte repräsentieren derzeit die Methode der Wahl zur Behandlung der Hypochondrischen Störung.

Fears of getting a severe disease (health anxiety) are widespread and their pathological manifestation as Hypochondriacal disorder (ICD-10) is cost-intensive for the health care system. In recent years advances in the research on and development of effective psychotherapeutic treatments have been made. Cognitive-behavioral therapy concepts currently are treatments of choice for Hypochondriacal disorder.

Schlüsselwörter:

Krankheitsangst - Hypochondrie - Krankheitsangststörung - Hypochondrische Störung

Keywords:

health anxiety - hypochondriacal disorder - hypochondriasis - illness anxiety disorder

• Literatur

• 1 Witthöft M, Kerstner T, Ofer J. et al. Cognitive biases in pathological health anxiety: The contribution of attention, memory, and evaluation processes. Clin Psychol Sci 2016; 4: 464-479
• 2 Görgen SM, Hiller W, Witthöft M. Health anxiety, cognitive coping, and emotion regulation: A latent variable approach. Int J Behav Med 2014; 21: 364-374
• 3 Clarke DM, Piterman L, Byrne CJ. et al. Somatic symptoms, hypochondriasis and psychological distress: a study of somatisation in Australian general practice. Medical J Australia 2008; 189: 560-564
• 4 Newby JM, Hobbs MJ, Mahoney AE J. et al. DSM-5 illness anxiety disorder and somatic symptoms disorder: Comorbidity, correlates, and overlap with DSM-IV hypochondriasis. J Psychosom Res 2017; 101: 31-37
• 5 Martin A, Jacobi F. Features of hypochondriasis and illness worry in the general population in Germany. Psychosom Med 2006; 68: 770-777
• 6 Starcevic V, Baggio S, Berle D. et al. Cyberchondria and its relationships with related constructs: a network analysis. Psychiatric Quaterly 2019; 90: 491-505
• 7 American Psychiatric Association. Diagnostic and statistical Manual of mental Disorders (DSM-5^®). Washington, DC: American Psychiatric Pub; 2013
• 8 World Health Organization. The ICD-10 Classification of mental and behavioural Disorders: clinical Descriptions and diagnostic Guidelines. Genf: World Health Organization; 1992
• 9 American Psychiatric Association. Diagnostic and statistical Manual of mental Disorders (DSM-IV^®). Washington, DC: American Psychiatric Pub; 2000
• 10 Bailer J, Kerstner T, Witthöft M. et al. Health anxiety and hypochondriasis in the light of DSM-5. Anxiety, Stress & Coping 2016; 29: 219-239
• 11 World Health Organization. International statistical classification of diseases and related health problems. 11. Ed. Genf: World Health Organization; 2018
• 12 Margraf J, Cwik JC, Suppiger A. et al. DIPS Open Access. Diagnostisches Interview bei Psychischen Störungen. Bochum: Ruhr-Universität Bochum, Forschungs- und Behandlungszentrum für psychische Gesundheit; 2017.
• 13 Beesdo-Baum K, Zaudig M, Wittchen HU. SCID-5-CV. Strukturiertes Klinisches Interview für DSM-5^®-Störungen – Klinische Version. Göttingen: Hogrefe; 2019
• 14 Wittchen HU, Pfister H, Garczynski E. CIDI. Composite International Diagnostic Interview nach ICD-10 und DSM-IV der WHO. Göttingen: Hogrefe; 1997
• 15 Weck F, Gropalis M, Neng JMB. et al. The German version of the H-YBOCS for the assessment of hypochondriacal cognitions and behaviors: Development, reliability and validity. Int J Behav Med 2013; 20: 618-626
• 16 Hiller W, Rief W. Internationale Skalen für Hypochondrie. Deutschsprachige Adaptation des Whiteley-Index (WI) und der Illness Attitude Scales (IAS) Bern: Huber; 2004
• 17 Bailer J, Rist F, Müller T. et al. Erfassung von Krankheitsängsten mit dem Short Health Anxiety Inventory (SHAI). Verhaltensther Verhaltensmed 2013; 34: 378-398
• 18 Witthöft M, Haaf A, Rist F. et al. Erfassung von Krankheitsangst mit dem Multidimensional Inventory of Hypochondriacal Traits (MIHT). Diagnostica 2010; 56: 2-12
• 19 American Psychiatric Association. Diagnostic and statistical Manual of mental Disorders (DSM-III^®). Washington, DC: American Psychiatric Pub; 1980
• 20 Weck F, Richtberg S, Neng JMB. et al. Epidemiology of hypochondriasis and health anxiety: Comparison of different diagnostic criteria. Curr Psychiatry Rev 2014; 10: 14-23
• 21 Bleichhardt G, Hiller W. Hypochondriasis and health anxiety in the German population. Br J Health Psychol 2010; 12: 511-523
• 22 Scarella TM, Laferton JAC, Ahern DK. et al. The relationship of hypochondriasis to anxiety, depression and somatoform disorders. Psychosomatics 2016; 57: 200-207
• 23 Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 2004; 56: 391-408
• 24 Weck F, Nagel LC, Richtberg S. et al. Personality disorders in hypochondriasis: a comparison to panic disorder and healthy controls. J Personality Disorders 2017; 30: 1-10
• 25 Noyes R, Kathol RG, Fisher MM. et al. Psychiatric comorbidity among patients with hypochondriasis. General Hospital Psychiatry 1994; 16: 78-87
• 26 Barsky AJ, Wyshak G. Hypochondriasis and somatosensory amplification. Br J Psychiatry 1990; 157: 404-409
• 27 Warwick HM, Salkovskis PM. Hypochondriasis. Behav Res Therapy 1990; 28: 105-107
• 28 Clark DM. A cognitive approach to panic. Behav Res Therapy 1986; 24: 461-470
• 29 Beck AT. Cognitive models of depression. J Cognitive Psychother 1987; 1: 5-37
• 30 Gropalis M, Bailer J, Weck F. et al. Optimierung von Expositionstherapie bei pathologischen Krankheitsängsten: Theoretische Grundlagen und praktische Implikationen. Psychotherapeut 2018; 63: 188-193
• 31 Fallon BA, Ahern DK, Pavlicova M. et al. A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis. Am JPsychiatry 2017; 174: 756-764
• 32 Bleichhardt G, Weck F. Kognitive Verhaltenstherapie bei Hypochondrie und Krankheitsangst. 3. Aufl. Heidelberg: Springer; 2015
• 33 Olatunji BO, Kauffman BY, Meltzer S. et al. Cognitive-behavioral therapy for hypochondriasis / health anxiety: a metaanalysis of treatment outcome and moderators, behavior research and therapy. Behav Res Therapy 2014; 58: 65-74
• 34 Hedman E, Axelsson E, Andersson E. et al. Exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder: randomised controlled trial. Br J Psychiatry 2016; 209: 407-413
• 35 Axelsson E, Andersson E, Ljótsson B. , et al. Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety. JAMA Psychiatry 2020; 77: 915-924
• 36 McManus F, Surawy C, Muse K. et al. A randomized clinical trial of mindfulness-based cognitive therapy versus unrestricted services. J Consulting Clin Psychol 2012; 80: 817-828
• 37 Eilenberg T, Fink P, Jensen JS. et al. Acceptance and commitment group therapy (ACT-G) for health anxiety: a randomized controlled trial. Psychol Med 2016; 46: 103-115
• 38 Sorensen P, Birket-Smith P, Wattar U. et al. A randomized clinical trial of cognitive behavioural therapy versus shortterm psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med 2011; 41: 431-441
• 39 Reimer C, Rüger U. Psychodynamische Psychotherapien. Lehrbuch der tiefenpsychologisch fundierten Psychotherapieverfahren. 3. Aufl. Heidelberg: Springer; 2006
• 40 Weck F, Neng JMB, Richtberg S. et al. Cognitive therapy versus exposure therapy for hypochondriasis (Health Anxiety): A randomized controlled trial. J Consulting Clin Psychol 2015; 83: 665-676
• 41 Weck F, Gropalis M, Hiller W. et al. Effectiveness of cognitivebehavioral group therapy for patients with hypochondriasis (health anxiety). J Anxiety Disorders 2015; 30: 1-7